Continuous Glucose Monitoring for Emergency Laparotomy
Launched by MEDICAL UNIVERSITY OF GDANSK · Dec 7, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The CLUE trial is a study that looks at whether continuous glucose monitoring (CGM) can help predict and prevent surgical site infections (SSIs) in patients undergoing emergency surgery for a serious abdominal condition called peritonitis. This trial is important because high or low blood sugar levels can affect recovery after surgery, and the researchers want to see if monitoring these levels continuously can make a difference in patient outcomes.
To participate in this trial, you need to be an adult aged 65 to 74 who is having emergency surgery for peritonitis and willing to give your written consent. Unfortunately, if you are receiving treatment for an open abdomen, you won't be eligible to participate. If you join the study, you'll wear a small device that continuously checks your blood sugar levels, allowing doctors to have better information about your health during recovery. This study is still in the planning stages and is not yet recruiting participants, but it could lead to better care for patients undergoing similar surgeries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • emergency laparotomy for peritonitis
- • written informed consent
- Exclusion Criteria:
- • - open abdomen treatment
About Medical University Of Gdansk
The Medical University of Gdańsk is a leading institution in healthcare education and research located in Gdańsk, Poland. Renowned for its commitment to advancing medical knowledge and improving patient outcomes, the university actively engages in innovative clinical trials across various medical disciplines. With a focus on multidisciplinary collaboration and state-of-the-art facilities, the Medical University of Gdańsk fosters an environment conducive to groundbreaking research and the development of novel therapeutic interventions. Its dedicated team of researchers, clinicians, and academic professionals is dedicated to enhancing healthcare through rigorous scientific inquiry and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gdańsk, Pomerania, Poland
Patients applied
Trial Officials
Piotr Spychalski, MD, PhD
Principal Investigator
MUG Division of General Surgery
Katarzyna Polomska
Principal Investigator
Medical University of Gdansk (MUG)
Jaroslaw Kobiela, Prof.
Principal Investigator
MUG Division of General Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials